Education
About Us
Working with TipRanks
Follow Us
RaQualia Pharma Inc. (JP:4579)
:4579
RESEARCH TOOLSreports
4579 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥301.00 - ¥728.00
Previous CloseN/A
Volume117.60K
Average Volume (3M)366.81K
Market Cap
¥12.89B
Enterprise Value¥22.38B
Total Cash (Recent Filing)¥2.76B
Total Debt (Recent Filing)¥3.34B
Price to Earnings (P/E)―
Beta0.67
Next Earnings
Aug 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding24,457,172
10 Day Avg. Volume156,160
30 Day Avg. Volume366,810
Financial Highlights & Ratios
PEG Ratio-8.20
Price to Book (P/B)4.70
Price to Sales (P/S)0.00
P/FCF Ratio17.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RaQualia Pharma Inc. News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.93% Public Companies and
Individual Investors
4579 FAQ
What was RaQualia Pharma Inc.’s price range in the past 12 months?
RaQualia Pharma Inc. lowest stock price was ¥301.00 and its highest was ¥728.00 in the past 12 months.
What is RaQualia Pharma Inc.’s market cap?
RaQualia Pharma Inc.’s market cap is ¥12.89B.
When is RaQualia Pharma Inc.’s upcoming earnings report date?
RaQualia Pharma Inc.’s upcoming earnings report date is Aug 14, 2025 which is in 35 days.
How were RaQualia Pharma Inc.’s earnings last quarter?
RaQualia Pharma Inc. released its earnings results on May 15, 2025. The company reported -¥0.24 earnings per share for the quarter, missing the consensus estimate of N/A by -¥0.24.
Is RaQualia Pharma Inc. overvalued?
According to Wall Street analysts RaQualia Pharma Inc.’s price is currently Overvalued.
Does RaQualia Pharma Inc. pay dividends?
RaQualia Pharma Inc. does not currently pay dividends.
What is RaQualia Pharma Inc.’s EPS estimate?
RaQualia Pharma Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RaQualia Pharma Inc. have?
RaQualia Pharma Inc. has 24,457,172 shares outstanding.
What happened to RaQualia Pharma Inc.’s price movement after its last earnings report?
RaQualia Pharma Inc. reported an EPS of -¥0.24 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.392%.
Which hedge fund is a major shareholder of RaQualia Pharma Inc.?
Currently, no hedge funds are holding shares in JP:4579
Company Description
RaQualia Pharma Inc.
RaQualia Pharma Inc. is a Japan-based pharmaceutical company engaged in the research, development, and commercialization of innovative pharmaceutical products. The company focuses on creating novel drugs primarily within the therapeutic areas of pain management, gastrointestinal disorders, and oncology. Through its dedication to advancing healthcare solutions, RaQualia Pharma strives to address unmet medical needs and improve patient outcomes.
Technical Analysis
Oncolys BioPharma, Inc.
―
StemRIM Inc.
―
CellSource Co., Ltd.
―
STELLA PHARMA CORPORATION
―
ReproCELL Inc.
―